Photodynamic therapy with visudyne in treatment of wet form of age-related macular degeneration - Two years results;Fotodynamická terapie s preparátem visudyne v léčbě vlhké formy věkem podmíně né makulární degenerace - Dvouleté výsledky

Casopis Lekaru Ceskych

Volumn 145, Issue 10, 2006, Pages 795-800

  Kolář, Petr ^a,b   Vizd'ova D ^a   Vlkova E ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b NONE   (Czech Republic)

Author keywords

Age related macular degeneration; Choriodal nevascular membrane; Fluorescence angiography; Photodynamic therapy with visudyne

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

AGED; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR DEGENERATION; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 33750408070     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Klein, R., Klein, B. E. K., Linton, K. L. P.: Prevalence of age-related maculopathy: the Beaver Eye Dam Study. Ophthalmology, 1992, 99, s. 933-944.
2. Eye Disease Case-Control Study Group: Risk factors for neovascular age-related macular degeneration. Arch. Ophthalmol., 1992, 110, s. 104-109.
3. Heiba, I. M., Elston, R. C., Klein, B. E., Klein, R.: Sibling Correlations and segregation analysis of age-related maculopathy: the Beaver Eye Dam Study. Genet. Epidemiol., 1994, 11, s. 51-67.
4. Schmidt-Erfurth, U., Miller, J. W., Sickenberg, M. et al.: Photodynamic therapy with verteporfin for chorioideal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch. Ophthalmol., 1999, 117, s. 1177-1187.
5. Alliston, B. A., Protchard, P. H., Levy, J. G.: Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivate. Br. J. Cancer, 1994, 69, s. 833-839.
6. Schmidt-Erfurth, U., Hassan, T.: Mechanism of action of photodynamic therapy with verteporfin for treatment of age-related macular degeneration. Surv. Ophthalmol., 2000, 45, s. 195-214.
7. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic Therapy of subfoveal choroidal neovascularization in age-related macular degenerationwith verteporfin. Two-year results of 2 randomized clinical trials - TAP Report 2. Arch. Ophthalmol., 2001, 119, s. 198-207.
8. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in Photodynamic Therapy Report 2. Am. J. Ophthalmol., 2001, 131, s. 541-560.
9. Soubrane, G., Kuhn, D., Coscas, G.: Indications for photodynamic therapy in age-related macular degeneration. J. Fr. Ophthalmol., 2004, 27, s. 79-80.
10. Coscas, G., Coscas, F., Soubrane, G.: Monitoring the patient after treatment: Angiographic aspect of recurrence and indications for retreatment. J. Fr. Ophthalmol., 2004, 27, s. 81-92.